EAM Global Investors’s Apyx Medical APYX Stock Holding History

EAM Global Investors’s Portfolio APYX Stock Details APYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-122,181	Closed	-$1.57M	–	202
2021 Q4	$1.57M	Buy	+122,181	New	+$1.71M	0.28%	173
2019 Q2	–	Sell	-157,453	Closed	-$994K	–	131
2019 Q1	$994K	Sell	157,453 -85,271	-35%	-$660K	0.44%	110
2018 Q4	$1.57M	Buy	242,724 +66,277	+38%	+$401K	0.86%	39
2018 Q3	$1.25M	Buy	+176,447	New	+$981K	0.51%	111

Other funds holding APYX

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

ACM

Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PVI

Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return

HKAM

Horizon Kinetics Asset Management New York $9.23B AUM 27.52% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

EAM Global Investors's APYX Position: Q1 2022 in Review

EAM Global Investors sold out of Apyx Medical (APYX) in Q1 2022, closing a stake of 122,181 shares — an estimated $1.57M sold.

EAM Global Investors first reported a position in APYX in Q3 2018 and held it in 4 quarters. The position peaked at $1.57M in Q4 2018. 71 funds tracked by Wall St. Rank hold APYX as of Q1 2022.

EAM Global Investors reported no remaining Apyx Medical position as of Q1 2022 after selling out during the quarter.
EAM Global Investors sold 122,181 Apyx Medical shares in Q1 2022, an estimated $1.57M.
EAM Global Investors first reported a position in Apyx Medical in Q3 2018 and held it in 4 quarters.
EAM Global Investors's Apyx Medical position peaked at $1.57M in Q4 2018.
71 funds tracked by Wall St. Rank held Apyx Medical as of Q1 2022.

Based on EAM Global Investors's 13F filing for Q1 2022, filed 13 May 2022.